HomepageBICO • STO
add
Bico Group
Vorige slotkoers
kr 28,60
Dag-range
kr 28,70 - kr 30,50
Jaar-range
kr 28,18 - kr 61,12
Beurswaarde
2,07Â mld. SEK
Gem. volume
165,46K
Koers/winst
-
Dividendrendement
-
Primaire beurs
STO
Marktnieuws
.INX
1,83%
1,65%
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(SEK) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 495,50Â mln. | -15,67% |
Bedrijfskosten | 312,80Â mln. | -7,57% |
Netto inkomsten | -246,20Â mln. | -252,22% |
Netto winstmarge | -49,69 | -317,56% |
Winst per aandeel | — | — |
EBITDA | 36,90Â mln. | -60,79% |
Effectief belastingtarief | -5,77% | — |
Balans
Totale activa
Totale passiva
(SEK) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 649,80Â mln. | 15,62% |
Totale activa | 5,47Â mld. | -38,24% |
Totale passiva | 2,70Â mld. | -7,93% |
Totaal aandelenvermogen | 2,77 mld. | — |
Uitstaande aandelen | 70,57 mln. | — |
Koers-boekwaardeverhouding | 0,73 | — |
Rendement op activa | -2,22% | — |
Rendement op kapitaal | -2,58% | — |
Kasstroom
Nettomutatie in liquide middelen
(SEK) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -246,20Â mln. | -252,22% |
Operationele kasstroom | 45,00Â mln. | 1.150,00% |
Kasstroom uit beleggingen | -27,30Â mln. | 73,08% |
Kasstroom uit financiering | -18,30Â mln. | 36,90% |
Nettomutatie in liquide middelen | -5,30Â mln. | 95,88% |
Vrije kasstroom | -269,76Â mln. | -250,45% |
Over
Bico Group is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics.
Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet.
The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Opgericht
27 jan 2016
Website
Werknemers
824